Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2013 by Boston Scientific Corporation.
Recruitment status was  Active, not recruiting
Pharmaceutical Research Associates
Medidata Solutions
Information provided by (Responsible Party):
Boston Scientific Corporation Identifier:
First received: June 21, 2010
Last updated: August 9, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2016
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)